Company Overview of Samsung Biologics Co., Ltd.
Samsung Biologics Co., Ltd. develops biological products through genetic engineering, cell culture technology, purification, and fill and finish technology. The company offers process development services, including cell line development programs, and upstream and downstream process development services, as well as develops, qualifies, and validates product-specific analytical methods. It also provides contract management services that comprise cGMP manufacturing programs for cell line development, process and analytical development, clinical phase I/II/III manufacturing, full-scale commercial manufacturing, and aseptic fill and finish operations. The company has a strategic alliance with Me...
Key Executives for Samsung Biologics Co., Ltd.
Chief Executive Officer, President and Director
Vice President of Corporate Business Operation Team
Chief Information Officer and Vice President
Executive Vice President and Director
Compensation as of Fiscal Year 2015.
Samsung Biologics Co., Ltd. Key Developments
Samsung Biologics Co., Ltd. Presents at BIO International Convention 2015, Jun-18-2015 11:30 AM
Jun 11 15
Samsung Biologics Co., Ltd. Presents at BIO International Convention 2015, Jun-18-2015 11:30 AM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: Jenifer L. Wheat, Vice President.
Samsung Biologics Co., Ltd. Presents at BIO International Convention, Jun-25-2014 03:15 PM
Jun 17 14
Samsung Biologics Co., Ltd. Presents at BIO International Convention, Jun-25-2014 03:15 PM. Venue: San Diego Convention Center, San Diego, California, United States.
Samsung Biologics Announces the Expansion of Existing Manufacturing Agreement with Bristol-Myers Squibb
Apr 23 14
Samsung BioLogics has announced that it has expanded its existing manufacturing agreement with Bristol-Myers Squibb. BMS's president of Global Manufacturing & Supply noted that the expanded agreement, will give the company flexibility to respond to increased demand in order to meet the global needs of patients. Details of which products will be covered by the deal or financial considerations have not yet been disclosed.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 3, 2015
February 5, 2015